Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (26)	9/24/1998 3:12:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 286

Anybody want to try and re-activate this thread? Hyseq trades at around book value. Here is the link the the last quarterly: sec.yahoo.com In which they make some interesting claims... The Company believes that its proprietary HyGenomics Database of partial human gene sequences is the largest such database in the world Recently in a Lehman report about biotech bottom fishing Hyseq was listed as a possibility (for bottom fishing) for the following reasons: 3Q98 announcement of second genomics collaberation 3Q98 first DNA array instrument sales from joint venture with Perkin Elmer 4Q98 announcement of third genomics collaberation Today the Wall Street Journal, in an article about the Bayer/Millennium deal, said "other genomics companies yesterday saw their stocks rise on Millennium's coattails". Myriad Genetics and Incyte were cited. Anyway Hyseq looks pretty interesting, but it is hard to make out what the affx lawsuit is all about. Anybody out there have any thoughts on that? Obligatory silly disclosure; I don't have any education in biology or genomics, but I have enjoyed cherry picking some of these little biotech stocks as they come down to around book value. I own 1000 shares of Hyseq at at cost of $4 1/2. I'll post this on the other Hyseq thread, and a link to this message on the affx and incy threads, maybe we can get some discussion going over here. --MM